Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:553-559
Published online before print August 3, 2009, doi: 10.1161/CIRCULATIONAHA.108.821082
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
120/7/553    most recent
CIRCULATIONAHA.108.821082v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Milan, D. J.
Right arrow Articles by MacRae, C. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milan, D. J.
Right arrow Articles by MacRae, C. A.
Related Collections
Right arrow Arrythmias-basic studies
Right arrow Functional genomics
Right arrow Genomics
Right arrow Ion channels/membrane transport
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Genetics of cardiovascular disease
Right arrowRelated Article

(Circulation. 2009;120:553-559.)
© 2009 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Drug-Sensitized Zebrafish Screen Identifies Multiple Genes, Including GINS3, as Regulators of Myocardial Repolarization

David J. Milan, MD; Albert M. Kim, MD, PhD; Jeffrey R. Winterfield, MD; Ian L. Jones, MS; Arne Pfeufer, MD; Serena Sanna, PhD; Dan E. Arking, PhD; Adam H. Amsterdam, PhD; Khaled M. Sabeh, MD; John D. Mably, PhD; David S. Rosenbaum, MD; Randall T. Peterson, PhD; Aravinda Chakravarti, PhD; Stefan Kääb, MD, PhD; Dan M. Roden, MD; Calum A. MacRae, MD, PhD

From the Cardiovascular Research Center, and Cardiology Division, Massachusetts General Hospital, Boston (D.J.M., A.M.K., J.R.W., I.L.J., K.M.S., R.T.P., C.A.M.); Department of Human Genetics, Helmholtz Center Munich, Germany National Research Center for Environmental Health, Neuherberg, and Department of Human Genetics, Technical University Munich, Munich, Germany (A.P.); QTSCD Consortium (A.P., S.S., D.E.A., A.C., S.K.); Istituto di Neurogenetica e Neurofarmacologia, CNR, Monserrato, Cagliari, Italy (S.S.); McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Md (D.E.A., A.C.); David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge (A.H.A.); Department of Cardiology, Children’s Hospital, Boston, Mass (J.D.M.); MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio (D.S.R.); Department of Medicine I, Ludwig Maximilians University Munich, Klinikum Großhadern, Munich, Germany (S.K.); and Departments of Medicine and Pharmacology, Vanderbilt University Medical Center, Nashville, Tenn (D.M.R.).

Correspondence to Dr David Milan or Dr Calum MacRae, Cardiovascular Research Center, 149 13th St, 4th Floor, Charlestown, MA 02129. E-mail dmilan{at}partners.org or cmacrae@partners.org

Received September 11, 2008; accepted May 15, 2009.

Background— Cardiac repolarization, the process by which cardiomyocytes return to their resting potential after each beat, is a highly regulated process that is critical for heart rhythm stability. Perturbations of cardiac repolarization increase the risk for life-threatening arrhythmias and sudden cardiac death. Although genetic studies of familial long-QT syndromes have uncovered several key genes in cardiac repolarization, the major heritable contribution to this trait remains unexplained. Identification of additional genes may lead to a better understanding of the underlying biology, aid in identification of patients at risk for sudden death, and potentially enable new treatments for susceptible individuals.

Methods and Results— We extended and refined a zebrafish model of cardiac repolarization by using fluorescent reporters of transmembrane potential. We then conducted a drug-sensitized genetic screen in zebrafish, identifying 15 genes, including GINS3, that affect cardiac repolarization. Testing these genes for human relevance in 2 concurrently completed genome-wide association studies revealed that the human GINS3 ortholog is located in the 16q21 locus, which is strongly associated with QT interval.

Conclusions— This sensitized zebrafish screen identified 15 novel myocardial repolarization genes. Among these genes is GINS3, the human ortholog of which is a major locus in 2 concurrent human genome-wide association studies of QT interval. These results reveal a novel network of genes that regulate cardiac repolarization.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 120: 543-545. [Extract] [Full Text]